↓ Skip to main content

Allergen-specific oral immunotherapy for peanut allergy

Overview of attention for article published in Cochrane database of systematic reviews, September 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Citations

dimensions_citation
85 Dimensions

Readers on

mendeley
168 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Allergen-specific oral immunotherapy for peanut allergy
Published in
Cochrane database of systematic reviews, September 2012
DOI 10.1002/14651858.cd009014.pub2
Pubmed ID
Authors

Ulugbek Nurmatov, Iris Venderbosch, Graham Devereux, F Estelle R Simons, Aziz Sheikh

Abstract

Peanut allergy is one of the most common forms of food allergy encountered in clinical practice.  In most cases, it does not spontaneously resolve; furthermore, it is frequently implicated in acute life-threatening reactions. The current management of peanut allergy centres on meticulous avoidance of peanuts and peanut-containing foods. Allergen-specific oral immunotherapy (OIT) for peanut allergy aims to induce desensitisation and then tolerance to peanut, and has the potential to revolutionise the management of peanut allergy. However, at present there is still considerable uncertainty about the effectiveness and safety of this approach.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 168 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Slovenia 1 <1%
Japan 1 <1%
United States 1 <1%
Korea, Republic of 1 <1%
Netherlands 1 <1%
Canada 1 <1%
Unknown 161 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 18%
Student > Bachelor 25 15%
Unspecified 23 14%
Researcher 21 13%
Other 20 12%
Other 48 29%
Unknown 1 <1%
Readers by discipline Count As %
Medicine and Dentistry 73 43%
Unspecified 29 17%
Agricultural and Biological Sciences 17 10%
Nursing and Health Professions 10 6%
Immunology and Microbiology 8 5%
Other 30 18%
Unknown 1 <1%

Attention Score in Context

This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2019.
All research outputs
#412,802
of 13,297,120 outputs
Outputs from Cochrane database of systematic reviews
#1,250
of 10,547 outputs
Outputs of similar age
#3,213
of 127,200 outputs
Outputs of similar age from Cochrane database of systematic reviews
#7
of 91 outputs
Altmetric has tracked 13,297,120 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,547 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.6. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,200 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.